Susanne Fiedler - 31 Mar 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Commercial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Susanne Fiedler
Issuer symbol
OGN
Transactions as of
31 Mar 2024
Net transactions value
-$75,256
Form type
4
Filing time
03 Apr 2024, 18:42:21 UTC
Previous filing
02 Apr 2024
Next filing
07 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +4,771 +12% $0.000000 43,473 31 Mar 2024 Direct
transaction OGN Common Stock Tax liability $28,576 -1,520 -3.5% $18.80 41,953 31 Mar 2024 Direct
transaction OGN Common Stock Options Exercise $0 +7,794 +19% $0.000000 49,747 31 Mar 2024 Direct
transaction OGN Common Stock Tax liability $46,680 -2,483 -5% $18.80 47,264 31 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -4,771 -50% $0.000000 4,772 31 Mar 2024 Common Stock 4,771 Direct F1, F2
transaction OGN Restricted Stock Units Options Exercise $0 -7,794 -33% $0.000000 15,590 31 Mar 2024 Common Stock 7,794 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
F3 On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.